Dupixent show sustained improvement in lung function in asthma patients

Pharma |  News | 0 Comment | 08 Sep, 2020

Regeneron Pharmaceuticals and Sanofi recently announced new results from a Dupixent® (dupilumab) Phase 3 open-l...Read more

Yiling Pharma receives first international approval for herbal COVID-19 medicine

Pharma |  News | 0 Comment | 07 Sep, 2020

  China-based Yiling Pharmaceutical recently issued a notice that it had received a certificate of drug registrati...Read more

New UltraPure - Advancing competitive edge for biotech and pharma

Pharma |  News | 0 Comment | 03 Sep, 2020

“To improve manufacturers’ ability to compete, the UltraPure portfolio optimizes pharma and biotech processe...Read more

CSafe Global opens new pharma hub in Taiwan

Pharma |  News | 0 Comment | 02 Sep, 2020

Headquartered in the USA, CSafe Global, the innovation leader in temperature-controlled container solutions for the tran...Read more

"6th Annual Biopharma Development and Production Week" set to go virtual

Pharma |  News | 0 Comment | 01 Sep, 2020

"6th Annual Biopharma Development and Production Week" conference to be held on 3rd - 5th Novem...Read more

FDA broadens EUA for Veklury (remdesivir) for Hospitalized COVID-19 Patients

Pharma |  News | 0 Comment | 31 Aug, 2020

The U.S. Food and Drug Administration broadened the scope of the existing emergency use authorization (EUA) for the drug...Read more

Celltrion initiates Ph I trial for COVID-19 drug in Korea

Pharma |  News | 0 Comment | 27 Aug, 2020

Celltrion Group has announced that the Korean Ministry of Food and Drug Safety (MFDS) has approved the company’s I...Read more

Eisai launches skin care products

Pharma |  News | 0 Comment | 27 Aug, 2020

Eisai Co., Ltd. announced that it has launched Sahne Medical Spray and Sahne Medical Cream (both are category-2 OTC drug...Read more

Intravacc, Therapyx develop world's first prophylactic gonorrhea vaccine

Pharma |  News | 0 Comment | 25 Aug, 2020

Dutch firm Intravacc, a global leader in translational research and development of viral and bacterial vaccines, ha...Read more

Eppendorf AG records strong first half-year 2020

Pharma |  News | 0 Comment | 25 Aug, 2020

  Consolidated revenue grows by 6.6% to €403.7 millionin the first six months  At €65.5 mill...Read more

Takeda divests consumer healthcare biz for JPY 242 B

Pharma |  News | 0 Comment | 24 Aug, 2020

Japan based Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest Tak...Read more

Australian researcher shares Low-Dose Ivermectin Therapy protocol for COVID-19

Pharma |  News | 0 Comment | 24 Aug, 2020

Australian triple therapy specialist Professor Thomas Borody, internationally famous for curing peptic ulcers using a tr...Read more

AI accelerates drug repurposing to find potential COVID-19 therapies, says GlobalData

Pharma |  Analysis | 0 Comment | 19 Aug, 2020

Out of all the different approaches available to find new therapies to treat COVID-19, drug repurposing is one of the fa...Read more

Hua Medicine, Bayer bring novel diabetes treatment in China

Pharma |  News | 0 Comment | 19 Aug, 2020

Bayer and Hua Medicine, a leading innovative drug development company, have announced a commercialization agreement and ...Read more

Chugai's Enspryng receives FDA approval for NMOSD

Pharma |  News | 0 Comment | 18 Aug, 2020

Tokyo based Chugai Pharmaceutical Co. Ltd., announced that the United States Food and Drug Administration (FDA) has appr...Read more

Isofol inks oncology deal with Solasia for $100M

Pharma |  News | 0 Comment | 18 Aug, 2020

Isofol Medical AB, Sweden has announced that it entered into a license agreement with Solasia Pharma K.K, a specialized ...Read more

AUM Biosciences establishes joint lab with SIgN

Pharma |  News | 0 Comment | 19 Aug, 2020

AUM Biosciences (AUM), a Singapore-headquartered clinical-stage biopharmaceutical company aiming to democratize R&D ...Read more

Ascletis Pharma announces first dosing of HBV patient in ASC22 trial

Pharma |  News | 0 Comment | 17 Aug, 2020

China-based Ascletis Pharma Inc. recently announced the dosing of the first HBV patient in Phase IIa clinical trial of A...Read more